Many vital research projects at the University of Auckland would simply not exist without philanthropy. The Freemasons Foundation’s latest commitment to the University’s Centre for Brain Research is a perfect example.
Alzheimer’s disease affects 50,000 New Zealanders today, but with the ageing population this is forecast to treble to 150,000 by 2050. The latest commitment from the Freemasons Foundation supports work which represents a new wave in the development of “blue skies” human brain research, of critical benefit for the ageing population in New Zealand and the world.
On-going support from the Freemasons Foundation has had huge impact in three main areas: Huntington’s disease, Neurogenesis and Alzheimer’s. Distinguished Professor Richard Faull, Director of the Centre for Brain Research, recognised the funding as being “transformational in establishing our brain research as world leading and pushing back the frontiers”. The potential for this work to develop new treatments has now been recognised and supported by internationally leading research groups and grant agencies.
Distinguished Professor Faull’s personal letter to the Freemasons Foundation acknowledges the incredible importance and impact of philanthropic support for the University’s cutting-edge human brain research. His video thanks the Foundation for their “dream funding”.
“Thank you so much for confirming the very generous support from the Freemasons Foundation to advance our research on human neurodegenerative diseases at the Centre for Brain Research.
It humbles me when we receive critical support like this that specifically funds our very promising and visionary graduate students and postdoctoral research fellows who are pursuing projects which are pushing back exciting new areas of knowledge which would not be funded by traditional sources because they are so cutting edge and innovative.
This generous and exciting funding from the Freemasons Foundation is a great investment in the training and future leadership development of young New Zealanders who are dedicated to helping people and families with Alzheimer’s, Parkinson’s and Huntington’s disease.
Thank you for your investment in the future of our brain research at the CBR.
Kindest regards and thanks,
We thank the Freemason’s Foundation for its outstanding commitment to transformational brain research, which is of critical importance for our ageing population.